Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)Andreas Dietz, Michael Flentje, Florian Hoppe et al.|European Archives of Oto-Rhino-Laryngology|2008Cited by 53
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Andreas Dietz, Gunnar Wichmann et al.|Frontiers in Oncology|2023Cited by 5